The weekly litigation news digest is live. Subscribe now

Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs - EP1976558

The patent EP1976558 was granted to Boehringer Ingelheim on Mar 15, 2017. The application was originally filed on Dec 28, 2006 under application number EP06850366A. The patent is currently recorded with a legal status of "Revoked".

EP1976558

BOEHRINGER INGELHEIM
Application Number
EP06850366A
Filing Date
Dec 28, 2006
Status
Revoked
Jun 2, 2023
Publication Date
Mar 15, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELI LILLYDec 14, 2017POTTER CLARKSON -

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2003170270
INTERNATIONAL-SEARCH-REPORTUS6497883
OPPOSITIONEP1926496
OPPOSITIONEP1976558
OPPOSITIONUS2003170270
OPPOSITIONUS2004132178
OPPOSITIONUS6703023
OPPOSITIONWO2005009462
OPPOSITIONWO2006072065
OPPOSITIONWO2007094893
SEARCHWO2006072065
SEARCHWO2007028823

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents